The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and Drug Administration (FDA) approval of the expanded indication of Alexion/AstraZeneca's eculizumab (Soliris) for pediatric patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback